Takeda Biopharmaceuticals India Private Limited, a global R&D-driven biopharmaceutical leader, has been certified as a Great Place To Work® in India for the period of March 2023 to March 2024. Focusing on four therapeutic areas—Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI)—Takeda India consistently strives to create a positive work environment for its employees.
The Great Place To Work® Institute is an international authority on workplace culture, serving businesses, non-profits, and government agencies in over 60 countries. Their research over the past three decades has established the essential characteristics of outstanding workplaces, which include strong leadership, consistent employee experience, and sustainable financial performance.
In India, the Institute partners with more than 1400 organizations annually across over 22 industries, assisting them in building High-Trust, High-Performance Cultures that deliver long-term business results. Takeda India’s certification showcases its dedication to fostering a culture where employees can thrive and contribute to the organization’s mission and values.
Takeda’s employees are committed to improving the quality of life for patients and working with healthcare partners in approximately 80 countries and regions. Their recognition as a Great Place to Work® in India highlights the company’s ongoing efforts to create a work environment that promotes growth, innovation, and collaboration.
